Results 151 to 160 of about 114,971 (282)
Nanomotor-Driven Extracellular Vesicles With Effective Tissue Penetration for Targeted Therapy of Primary Ovarian Insufficiency. [PDF]
Mu Y +7 more
europepmc +1 more source
Abstract Background Persistent breeding‐induced endometritis (PBIE) is a common reason for mares failing to establish pregnancy. Objective To examine the hypothesis that advancing mare age and embryo donor status predispose to PBIE and compromise fertility.
Tom Stout +3 more
wiley +1 more source
Diagnostic accuracy of AMH for primary ovarian insufficiency/premature ovarian failure: a real-world cohort study. [PDF]
Mao S, Yang D, Wang X, Cao X.
europepmc +1 more source
Abstract Genetic tumor risk syndromes (genturis) contribute substantially to the overall cancer burden and provide opportunities for early detection, prevention, and individualized treatment. Yet, many affected individuals remain undiagnosed due to restrictive testing criteria and challenges in variant interpretation.
Mayra Sauer +11 more
wiley +1 more source
A TAp63alpha truncating variant associated with primary ovarian insufficiency lowers the cellular apoptotic rate. [PDF]
Moleri S +4 more
europepmc +1 more source
Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency
Rachel K Vanderschelden +5 more
semanticscholar +1 more source
Living at genetic risk: The patient experience of Lynch syndrome
Abstract Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk of ovarian, gastric, small bowel, pancreatic, biliary urothelial, brain,
Nicola Reents +2 more
wiley +1 more source
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia +4 more
wiley +1 more source
What's New? Epithelial ovarian cancer (EOC) is a severe malignancy with few effective treatment options. While the mechanisms remain unclear, changes in lipid metabolism may fuel tumor growth and EOC progression, offering a possible path for new treatments.
Hitomi Sakaguchi‐Mukaida +10 more
wiley +1 more source
An Evidence-Based Approach to the Management of Primary Ovarian Insufficiency in Adolescents and Young Women. [PDF]
Bakhsh H.
europepmc +1 more source

